LAUREN PODOLL: Open Payments
NPI 1336851278 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,416 in 142 payments from 32 companies in 2025. Trend: 2023 $2,011 · 2024 $2,612 · 2025 $3,416
Food & beverage: $3,416
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 14 | $500 |
| Amgen Inc. | 13 | $309 |
| Astellas Pharma US Inc | 10 | $307 |
| Novo Nordisk Inc | 15 | $304 |
| Corcept Therapeutics | 19 | $250 |
| Medtronic, Inc. | 7 | $167 |
| Lilly USA, LLC | 6 | $142 |
| Ascendis Pharma Endocrinology Inc | 5 | $124 |
| BETA BIONICS, INC. | 6 | $120 |
| SANOFI-AVENTIS U.S. LLC | 3 | $118 |
Products named: Omnipod, Veozah, Korlym, EVENITY, MINIMED 780G, Ozempic, Yorvipath, iLet Bionic Pancreas.
Industry payments across SC — which companies pay providers there.
